Concorde Asset Management, LLC Abbott Laboratories Transaction History
Concorde Asset Management, LLC
- $173 Million
- Q3 2024
A detailed history of Concorde Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Concorde Asset Management, LLC holds 2,146 shares of ABT stock, worth $255,266. This represents 0.14% of its overall portfolio holdings.
Number of Shares
2,146
Previous 2,277
5.75%
Holding current value
$255,266
Previous $236,000
3.39%
% of portfolio
0.14%
Previous 0.15%
Shares
14 transactions
Others Institutions Holding ABT
# of Institutions
3,185Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$20 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$9.13 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.82 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.34 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $208B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...